Research And Development Expense of MediWound Ltd. from 31 Dec 2015 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD
Summary
MediWound Ltd. annual and quarterly Research And Development Expense in USD history and change rate from 31 Dec 2015 to 31 Dec 2024.
  • MediWound Ltd. Research And Development Expense for the quarter ending 30 Jun 2024 was $1,898,000, a 6.2% decline year-over-year.
  • MediWound Ltd. annual Research And Development Expense for 2024 was $8,878,000, a 19% increase from 2023.
  • MediWound Ltd. annual Research And Development Expense for 2023 was $7,467,000, a 27% decline from 2022.
  • MediWound Ltd. annual Research And Development Expense for 2022 was $10,181,000, a 0.73% decline from 2021.
Source SEC data
View on sec.gov
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Change (%)
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Change (%)

MediWound Ltd. Annual Research And Development Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $8,878,000 +$1,411,000 +19% 01 Jan 2024 31 Dec 2024 20-F 19 Mar 2025 2024 FY
2023 $7,467,000 -$2,714,000 -27% 01 Jan 2023 31 Dec 2023 20-F 19 Mar 2025 2024 FY
2022 $10,181,000 -$75,000 -0.73% 01 Jan 2022 31 Dec 2022 20-F 19 Mar 2025 2024 FY
2021 $10,256,000 +$2,558,000 +33% 01 Jan 2021 31 Dec 2021 20-F 21 Mar 2024 2023 FY
2020 $7,698,000 +$2,729,000 +55% 01 Jan 2020 31 Dec 2020 20-F 16 Mar 2023 2022 FY
2019 $4,969,000 +$897,000 +22% 01 Jan 2019 31 Dec 2019 20-F 17 Mar 2022 2021 FY
2018 $4,072,000 -$1,390,000 -25% 01 Jan 2018 31 Dec 2018 20-F 25 Feb 2021 2020 FY
2017 $5,462,000 -$1,606,000 -23% 01 Jan 2017 31 Dec 2017 20-F 25 Feb 2020 2019 FY
2016 $7,068,000 +$1,047,000 +17% 01 Jan 2016 31 Dec 2016 20-F 25 Mar 2019 2018 FY
2015 $6,021,000 01 Jan 2015 31 Dec 2015 20-F 19 Mar 2018 2017 FY

MediWound Ltd. Quarterly Research And Development Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $1,898,000 -$126,000 -6.2% 01 Apr 2024 30 Jun 2024 6-K 14 Aug 2024 2023 Q2
Q2 2023 $2,024,000 -$167,000 -7.6% 01 Apr 2023 30 Jun 2023 6-K 14 Aug 2024 2023 Q2
Q2 2022 $2,191,000 -$465,000 -18% 01 Apr 2022 30 Jun 2022 6-K 15 Aug 2023 2023 Q2
Q2 2021 $2,656,000 +$1,044,000 +65% 01 Apr 2021 30 Jun 2021 6-K 09 Aug 2022 2022 Q2
Q2 2020 $1,612,000 +$1,440,000 +837% 01 Apr 2020 30 Jun 2020 6-K 10 Aug 2021 2021 Q2
Q2 2019 $172,000 -$1,364,000 -89% 01 Apr 2019 30 Jun 2019 6-K/A 30 Oct 2020 2020 Q2
Q2 2018 $1,536,000 -$128,000 -7.7% 01 Apr 2018 30 Jun 2018 6-K 12 Aug 2019 2019 Q2
Q2 2017 $1,664,000 01 Apr 2017 30 Jun 2017 6-K 07 Aug 2018 2018 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.